The foreign‐body phagocytic capacity of KCs has been reported to be lower in NAFLD in both humans (Shida et al., 2018) and animal models (Tsujimoto et al., 2008). This evidence concerns the gene TBCE and metabolic dysfunction-associated steatotic liver disease.